L’anticorps anti-MEGF8 Polyclonal Lapin est utilisé pour la détection de MEGF8 dans des échantillons de Humain, Souris et Rat. Il a été validé pour ELISA, WB, IHC et IF.
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,ELISA 1:20000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
MEGF8
(Multiple EGF-Like-Domains 8 (MEGF8))
Autre désignation
EGFL4
Sujet
MEGF8, C19orf49, EGFL4, KIAA0817, Multiple epidermal growth factor-like domains protein 8, Multiple EGF-like domains protein 8, Epidermal growth factor-like protein 4, EGF-like protein 4Multiple EGF like domains 8 encoded by MEGF8 is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in MEGF8 are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for MEGF8.